The approval Journey Medical received from FDA for Emrosi makes DERM an exciting stock. Click here to read more.

Vertex Pharmaceuticals (VRTX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Terence ...

Morgan Stanley analyst Terence Flynn has maintained their neutral stance on MRK stock, giving a Hold rating yesterday.Invest with Confidence: ...

Walmart, CVS, Amazon and other well known retailers may have carried the recalled product, which the FDA calls out unique ...

PHOENIX (AZFamily) — A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression. The hallucinogenic drug is an option when traditional treatment isn’t ...

Operator Good day, and welcome to the Altria Group 2024 fourth quarter and full year earnings conference call. [Operator ...

The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail. MALMÖ, SE / ACCESS Newswire / January ...

In his first Senate confirmation hearing to be secretary of the Department of Health and Human Services, Robert F. Kennedy Jr ...

2025 is a truly pivotal year, expected to end with the commercialization of our first AI-based Software as a Medical Device, ...

Merck , known as MSD outside of the United States and Canada, announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended the ...

The Nvidia RTX 5090 is an absolute powerhouse of a GPU, and it's unsurprisingly going to be in high demand. Here's where we ...